Research location
Coquitlam
British Columbia, Canada
Advertisement
Research activity in Coquitlam
British Columbia, CanadaCureCurrent currently publishes aggregate city-level research activity for this location: 52 trials and 56 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Coquitlam
52 linked trials · page 1 of 2An Observational Study to Assess the Canagliflozin Treatment in Type 2 Diabetes Mellitus in a Usual Clinical Practice in CanadaNCT02688075 · 2015-11-13 · 1 site observation
COMPLETED
Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 DiabetesNCT02461589 · 2015-09-21 · 1 site observation
COMPLETED
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney DiseaseNCT02540993 · 2015-09-17 · 1 site observation
COMPLETED
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney DiseaseNCT02545049 · 2015-09-17 · 1 site observation
COMPLETED
Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.NCT02296138 · 2015-01-13 · 1 site observation
COMPLETED
A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration AlgorithmsNCT02298192 · 2014-11-21 · 1 site observation
COMPLETED
A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes MellitusNCT01989754 · 2014-01-16 · 1 site observation
COMPLETED
Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 DiabetesNCT01778049 · 2013-01-01 · 1 site observation
COMPLETED
Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 DiabetesNCT01719003 · 2012-10-01 · 2 site observations
COMPLETED
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 DiabetesNCT01617434 · 2012-09-01 · 1 site observation
COMPLETED
Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 DiabetesNCT01606007 · 2012-07-01 · 1 site observation
COMPLETED
Linagliptin in Combination With Metformin in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic ControlNCT01438814 · 2011-11-01 · 1 site observation
COMPLETED
Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and MetforminNCT01388361 · 2011-09-01 · 1 site observation
COMPLETED
A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly PeopleNCT01259297 · 2011-01-01 · 1 site observation
TERMINATED
Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus RegimenNCT01165684 · 2010-10-01 · 1 site observation
COMPLETED
Effects of a Dietary Fibre Supplementation of a Low Calorie Diet on Appetite and Body WeightNCT01109199 · 2010-08-01 · 2 site observations
COMPLETED
Evaluation of Subjective Ratings of Appetite and Glucoregulation of a Low Calorie Diet Supplemented With a High Viscosity Polysaccharide (PolyGlycopleX - PGX)NCT01108328 · 2010-06-01 · 2 site observations
COMPLETED
A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)NCT01075282 · 2010-02-01 · 1 site observation
COMPLETED
CANVAS - CANagliflozin cardioVascular Assessment StudyNCT01032629 · 2009-12-09 · 1 site observation
COMPLETED
Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 DiabetesNCT00982644 · 2009-09-01 · 1 site observation
COMPLETED
Canadian Study of Trandolapril on Blood Pressure in Hypertensive PatientsNCT01078584 · 2008-12-01 · 2 site observations
COMPLETED
Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 DiabetesNCT00789191 · 2008-11-01 · 1 site observation
COMPLETED
Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)NCT00676338 · 2008-11-01 · 1 site observation
COMPLETED
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 DiabetesNCT00736879 · 2008-09-22 · 1 site observation
COMPLETED
Effect of a Soluble Fibre Blend and Medium Chain Triglycerides on Body Composition and Cardiometabolic Risk FactorsNCT00644098 · 2008-09-01 · 1 site observation
COMPLETED
A Diabetes Study to Treat A Population Previously Not at TargetNCT00747149 · 2008-05-01 · 1 site observation
COMPLETED
An Efficacy, Safety, and Tolerability Study of Canagliflozin (JNJ-28431754) in Patients With Type 2 DiabetesNCT00642278 · 2008-04-01 · 1 site observation
COMPLETED
Effect of PF-00734200 in Subjects With Type 2 DiabetesNCT00618007 · 2008-02-01 · 1 site observation
COMPLETED
Open Label Study Telmisartan and Amlodipine in HypertensionNCT00614380 · 2008-01-01 · 1 site observation
COMPLETED
A Trial In Diabetic Patients To Assess Effect Of CE-326,597 On Glucose Control And Body WeightNCT00542009 · 2007-12-01 · 1 site observation
COMPLETED
Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant HypertensionNCT00558428 · 2007-10-01 · 1 site observation
COMPLETED
A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic PatientsNCT00391196 · 2006-11-01 · 1 site observation
TERMINATED
A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. MetforminNCT00386100 · 2006-10-01 · 1 site observation
COMPLETED
Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of HypertensionNCT00281593 · 2006-04-01 · 1 site observation
COMPLETED
A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes MellitusNCT00282971 · 2006-03-06 · 1 site observation
TERMINATED
G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study)NCT00255645 · 2005-09-01 · 1 site observation
TERMINATED
Risperidone LA Heathcare Resource StudyNCT00272597 · 2005-09-01 · 1 site observation
COMPLETED
A Study In Patients With Type 2 Diabetes MellitusNCT00256867 · 2005-08-18 · 1 site observation
COMPLETED
Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin AloneNCT00121667 · 2005-08-01 · 1 site observation
COMPLETED
Study of Muraglitazar Versus Pioglitazone in Type 2 DiabetesNCT00106808 · 2005-08-01 · 1 site observation
COMPLETED
A New Oral Treatment For Type II Diabetes MellitusNCT00111800 · 2005-04-28 · 1 site observation
COMPLETED
GALLEX 1 - Long Term Extension Study in Patients With Type 2 DiabetesNCT00252876 · 2005-03-01 · 1 site observation
TERMINATED
Study In Asthma ControlNCT00273026 · 2004-11-08 · 1 site observation
TERMINATED
Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate HypertensionNCT00095550 · 2004-10-01 · 1 site observation
COMPLETED
Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe HypertensionNCT00095394 · 2004-09-01 · 1 site observation
COMPLETED
GALLANT 8 Tesaglitazar Add-on to MetforminNCT00251953 · 2004-07-01 · 1 site observation
TERMINATED
A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II DiabeticsNCT00067951 · 2003-10-17 · 1 site observation
COMPLETED
Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes SubjectsNCT00499707 · 2003-10-08 · 1 site observation
COMPLETED
PPAR - Combination With MetforminNCT00162240 · 2003-06-01 · 1 site observation
COMPLETED
A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic ControlNCT00246987 · 2003-06-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.